Shizuoka, Japan

Kosuke Ito

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Api Corporation. Active years: 2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kosuke Ito. Retrieved from https://idiyas.com/inventor/kosuke-ito-blkmb8cl

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2019

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kosuke Ito: Innovator in Pharmaceutical Chemistry

Introduction

Kosuke Ito is a notable inventor based in Shizuoka, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of methods for producing important compounds.

Latest Patents

Ito holds a patent for "Rosuvastatin calcium and process for producing intermediate thereof." The objective of this invention is to provide a novel method capable of producing rosuvastatin calcium and its intermediates efficiently, inexpensively, and with high purity. This method allows for the industrial-scale production of rosuvastatin calcium without the need for extremely low temperature reactions or special asymmetric catalysts.

Career Highlights

Kosuke Ito is associated with Api Corporation, where he applies his expertise in pharmaceutical development. His work focuses on improving production processes for vital medications, contributing to advancements in healthcare.

Collaborations

Ito collaborates with talented professionals in his field, including Naoyuki Watanabe and Tomoko Maeda. Their combined efforts enhance the innovation and efficiency of pharmaceutical processes.

Conclusion

Kosuke Ito's contributions to pharmaceutical chemistry, particularly through his patent on rosuvastatin calcium, highlight his role as an innovator in the industry. His work continues to impact the field positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…